A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 33938
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MS
Long Form : multiple sclerosis
No. Year Title Co-occurring Abbreviation
2021 Astaxanthin Reduces Demyelination and Oligodendrocytes Death in A Rat Model of Multiple Sclerosis. AST, CNS, DMSO, IHC, LFB, MBP, MOG, PDGFR-alpha, RT-PCR
2021 Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone. EAE, IL-1beta, TLR4
2021 Transcription cofactor GRIP1 differentially affects myeloid cell-driven neuroinflammation and response to IFN-beta therapy. EAE, GCs, GRIP1, IFN-beta, MG
2020 "I'm in a very good frame of mind": a qualitative exploration of the experience of standing frame use in people with progressive multiple sclerosis. RCT
2020 "Ode to confidence": Poetry groups for dysarthria in multiple sclerosis. ---
2020 'I can do this': a qualitative exploration of acceptability and experiences of a physical activity behaviour change intervention in people with multiple sclerosis in the UK. ---
2020 'I want to be with you, but I have MS': Challenges of interpersonal relationships from the MS patients' point of view. ---
2020 'It struck at the heart of who I thought I was': A meta-synthesis of the qualitative literature examining the experiences of people with multiple sclerosis. ---
2020 'Posture second' strategy predicts disability progression in multiple sclerosis. DTC
10  2020 'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting. CNS, IL
11  2020 12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate. CSF, GA, NMR, PTX-3
12  2020 18F-FAC PET Visualizes Brain-Infiltrating Leukocytes in a Mouse Model of Multiple Sclerosis. 18F-CFA, 18F-FAC, BBB, EAE
13  2020 18F-THK5351 PET Can Identify Astrogliosis in Multiple Sclerosis Plaques. ---
14  2020 2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions. 2-AG, CSPGs, OPC
15  2020 60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments. DALYs, GBD
16  2020 7T MPFLAIR versus MP2RAGE for Quantifying Lesion Volume in Multiple Sclerosis. FLAIR, MP2RAGE, MPFLAIR, MRI, WML
17  2020 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. CLs, CSF, FLAIR, GM, LME, MP2RAGE, MRI, RRMS, TLs, WM
18  2020 A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes. EDSS, RRMS
19  2020 A Brief Review of the Effects of Vitamin D on Multiple Sclerosis. ---
20  2020 A case of drug-induced bullous pemphigoid associated with teriflunomide: A patient with relapsing multiple sclerosis. RMS
21  2020 A Case of Intermittent Exercise-Induced Foot Drop in a Recreational Runner. MRI
22  2020 A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature. CNS, DMTs, GVHD, HSCT, MOG, NMO
23  2020 A Case of Severe Multiple Sclerosis Manifesting upon GnRH Agonist Therapy for Uterine Fibroids. GnRH
24  2020 A Case Report of Parry-Romberg Syndrome Misdiagnosed as Multiple Sclerosis. PRS
25  2020 A case report with tuberculous meningitis during fingolimod treatment. CSF, MRI
26  2020 A clinical screening tool for objective and subjective cognitive disorders in multiple sclerosis. FSS, HADS, SDMT, VASs
27  2020 A clinically feasible 7-Tesla protocol for the identification of cortical lesions in Multiple Sclerosis. CLs, GM, ICC
28  2020 A common genetic variant rs2821557 in KCNA3 is linked to the severity of multiple sclerosis. MSSS
29  2020 A comparative study for the intermediate states of myelin oligodendrocyte glycoprotein in the absence and presence of glycan - A computational approach. MOG
30  2020 A comparative study of uncertainty and coping strategies of patients with multiple sclerosis for members and nonmembers in peer groups. ---
31  2020 A comparison study of inhomogeneous magnetization transfer (ihMT) and magnetization transfer (MT) in multiple sclerosis based on whole brain acquisition at 3.0T. EDSS, HWM, ihMT, MT, NAWM, RRMS
32  2020 A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis. AIH, AILD, IF, NCs, PBC
33  2020 A Comprehensive Approach to Disentangle the Effect of Cerebellar Damage on Physical Disability in Multiple Sclerosis. 25-FWT, COP, DTI, EDSS, FA, HS, MRI, TBSS
34  2020 A comprehensive review of non-coding RNAs functions in multiple sclerosis. ncRNA
35  2020 A Controlled Descriptive Study to Determine the Nutritional Status and Biochemical Parameters of Multiple Sclerosis Patients. ---
36  2020 A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis. EDSS, MRI, SPMS
37  2020 A critical analysis of helminth immunotherapy in multiple sclerosis. HIT
38  2020 A critical role for expression of atypical chemokine receptor 2 in multiple sclerosis: A preliminary project. PBMCs, qPCR, RRMS
39  2020 A current understanding of multiple sclerosis. ---
40  2020 A Deep Learning Approach to Diagnosing Multiple Sclerosis from Smartphone Data. ---
41  2020 A Descriptive Cross-Sectional Study of Manipulative Dexterity on Different Subtypes of Multiple Sclerosis. PPT
42  2020 A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls. CMV, EBNA-1, EBV, PEI, PwMS, PwMS, VCA
43  2020 A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. CNS, EAE, PPARgamma, UA
44  2020 A feasibility study of a manualized resilience-based telehealth program for persons with multiple sclerosis and their support partners. PwMS
45  2020 A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19. COVID-19
46  2020 A fully automated pipeline for brain structure segmentation in multiple sclerosis. ---
47  2020 A Fully Automatic Method for Optic Radiation Tractography Applicable to Multiple Sclerosis Patients. OR, ROC
48  2020 A fully convolutional neural network for new T2-w lesion detection in multiple sclerosis. DFs, FCNN, MRI
49  2020 A genetic variant of pri-miR-182 may impact the risk for the onset of multiple sclerosis in the Iranian population. ---
50  2020 A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications. PwMS
51  2020 A Head-to-Head Comparison of an Isometric and a Concentric Fatigability Protocol and the Association With Fatigue and Walking in Persons With Multiple Sclerosis. 6MWT, MFIS
52  2020 A Journey to the Conformational Analysis of T-Cell Epitope Peptides Involved in Multiple Sclerosis. ALPs, CNS, HLA, MBP, MOG, PLP, TCR
53  2020 A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis. IFN-beta-1b, MRI, MxA, SOCS3, USP18
54  2020 A longitudinal study of cognitive function in multiple sclerosis: is decline inevitable? CIS, RR
55  2020 A matched case-control study of risk factors associated with multiple sclerosis in Kuwait. ---
56  2020 A Meta-Analytic Review of the Value of miRNA for Multiple Sclerosis Diagnosis. miRNAs, RRMS
57  2020 A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-beta1a in multiple sclerosis patients. IM IFNbeta-1a
58  2020 A Modified MCT-Based Ketogenic Diet Increases Plasma beta-Hydroxybutyrate but Has Less Effect on Fatigue and Quality of Life in People with Multiple Sclerosis Compared to a Modified Paleolithic Diet: A Waitlist-Controlled, Randomized Pilot Study. MCT, QOL
59  2020 A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis. FMZ, GABA, HC, PET, VTr
60  2020 A multi-modal virtual reality treadmill intervention for enhancing mobility and cognitive function in people with multiple sclerosis: Protocol for a randomized controlled trial. ---
61  2020 A multi-shell multi-tissue diffusion study of brain connectivity in early multiple sclerosis. CIS
62  2020 A Multidimensional Assessment of Metacognition Across Domains in Multiple Sclerosis. RRMS
63  2020 A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. CIS, DP, LV, SDMT, sNfL
64  2020 A Multiple N-Glucosylated Peptide Epitope Efficiently Detecting Antibodies in Multiple Sclerosis. N-Glc, PEG, SP-ELISA
65  2020 A new lipophilic amino alcohol, chemically similar to compound FTY720, attenuates the pathogenesis of experimental autoimmune encephalomyelitis by PI3K/Akt pathway inhibition. CNS, EAE
66  2020 A new look at an old test: Normative data of the symbol digit modalities test -Oral version. SDMT
67  2020 A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells. CXCR5, CYP24A1, TSFM
68  2020 A new target for the treatment of inflammatory bowel disease: Interleukin-37. DCs, IBD, IL, RA, SLE
69  2020 A novel CNS-homing peptide for targeting neuroinflammatory lesions in experimental autoimmune encephalomyelitis. CNS, EAE
70  2020 A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study. SDMT
71  2020 A novel role of cardiac inwardly rectifying potassium channels explaining autonomic cardiovascular dysfunctions in a cuprizone-induced mouse model of multiple sclerosis. CNS, CV, ECG
72  2020 A Novel, Integrative Approach for Evaluating Progression in Multiple Sclerosis: Development of a Scoring Algorithm. SPMS
73  2020 A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. CSF, NF-kappaB, RNA-Seq, RRMS, scIg-Seq, scRNA-seq
74  2020 A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study. AUC, EDSS, ROC, RRMS, SPMS
75  2020 A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients. PPMS, SPMS
76  2020 A Polymorphism Within the MBP Gene Is Associated With a Higher Relapse Number in Male Patients of Multiple Sclerosis. MBP, SNP
77  2020 A Population-Based Investigation of Health-Care Needs and Preferences in American Adults With Multiple Sclerosis. ---
78  2020 A possible link between intracranial lipomas and localization-related relapses in multiple sclerosis. IL
79  2020 A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development. ---
80  2020 A preliminary study of the concentration of metallic elements in the blood of patients with multiple sclerosis as measured by ICP-MS. ICP-MS
81  2020 A Randomized, Triple-blind Placebo-controlled Trial to Determine the Effect of Saffron on the Serum Levels of MMP-9 and TIMP-1 in Patients with Multiple Sclerosis. CNS, MMP, RRMS, TIMP-1
82  2020 A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test. CoRe, SDMT
83  2020 A realist review of advance care planning for people with multiple sclerosis and their families. ACP, RAMESES
84  2020 A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis. DMF
85  2020 A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective. AD, ALS, ASDs, CNS, KD, PD
86  2020 A roadmap to precision medicine for multiple sclerosis. ---
87  2020 A Scope of the Social Brain in Multiple Sclerosis: Insights From Neuroimaging Studies. ---
88  2020 A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course. CHI3L1, CSF, EDSS, GFAP, NfL, OND, RRMS
89  2020 A Scoring Algorithm for Deriving Utility Values from the Neuro-QoL for Patients with Multiple Sclerosis. IRT, NQU
90  2020 A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS). AI, BICAMS, HC, ICA, NFL, SDMT
91  2020 A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. ADA, CSF, SNP
92  2020 A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting. BDI-II, DMF, DMTs, FSS, INF, PROs, PwMS, RR, SDMT, TERI, TSQM
93  2020 A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project. ASD, DMDs, RR
94  2020 A Systematic Review of Cerebral Functional Near-Infrared Spectroscopy in Chronic Neurological Diseases-Actual Applications and Future Perspectives. AD, fNIRS, MCI, PD
95  2020 A systematic review of morbidities suggestive of the multiple sclerosis prodrome. ---
96  2020 A Systematic Review on the Role of Arachidonic Acid Pathway in Multiple Sclerosis. AA, EAE
97  2020 A Tolerogenic Role of Cathepsin G in a Primate Model of Multiple Sclerosis: Abrogation by Epstein-Barr Virus Infection. ---
98  2020 A Tunable-Q wavelet transform and quadruple symmetric pattern based EEG signal classification method. EEG, k-NN, NCA, PD, QSP, TQWT
99  2020 A validation study for remote testing of cognitive function in multiple sclerosis. CVLT-II, SDMT
100  2020 A validation study of manual atrophy measures in patients with MultipleSclerosis. EDSS